Aimns-Tissue fibrosis is a common and serious consequence of chronic inflammation. The mechanism linking these two processes is poorly understood. The present study has utilised a human in vivo model of a delayed type hypersensitivity (DTH) reaction, the tuberculin Heaf reaction, induced by intradermal tuberculin in BCG immunised subjects, to dissect the relation between these two processes. Methods-Punch skin biopsy specimens were obtained on day 5, day 13 and six to 16 weeks following the tuberculin Heaf test in 18 subjects with grade 3 or 4 responses. Skin biopsy specimens from six subjects served as controls. The specimens were examined using immunohistochemical staining for type 1 procollagen and transforming growth factor-P (TGF-P), as well as in situ hybridisation for type 1 procollagen messenger RNA (mRNA). Results-Immunohistochemical analysis
revealed increased deposition of TGF-P in tissue matrix in the biopsy specimens obtained on day 5 following the tuberculin Heaf test. There was also extensive type 1 procollagen staining in the biopsy specimens obtained as early as day 5. Procollagen-i staining was maximal on day 13 , and was present in biopsy specimens from tuberculin Heaf test sites up to eight weeks after the tuberculin inoculation. The type 1 procollagen was localised within cells surrounding areas of inflammatory infiltrate and in perivascular tissues. The presence of new collagen formation was confirmed by in situ hybridisation using oligonucleotide probes for type 1 procollagen mRNA in cells in sections from biopsy specimens obtained on day 13. Conclusions-These data from a human in vivo model of a DTH response indicate that the immune response is intimately associated with an increase in the production ofgrowth factors and the initiation The persistence of chronic inflammation is commonly associated with progression to tissue fibrosis and permanent organ damage. This is a special problem in the lungs, where it may occur in many interstitial lung diseases, sarcoidosis and untreated tuberculosis. Bronchoalveolar lavage and biopsy studies in these diseases have documented an increase in inflammatory cells,' increases in messenger RNA (mRNA) and protein of growth factors such as platelet derived growth factor-13 (PDGF(B)) and transforming growth factor-n (TGF-0)2 '6 as well as evidence of new collagen formation. 6 However, it is not clear how the immune and inflammatory reactions are linked to the production of growth factors and the development of fibrosis.
Pulmonary tuberculosis serves as a human disease model of chronic inflammation progressing to lung fibrosis, in which the pathogen and much of the immunology are known. In tuberculosis, purified protein derivative (PPD) specific T cell clones produce interleukin-2 (IL-2) and interferon-y (IFN-y 7 2) and were trypsinised (0 5% trypsin and 0 5% chymotrypsin; Sigma) for 10 minutes for type 1 procollagen and 20 minutes for TGF-1.
Non-specific protein binding was blocked with 1 in 5 dilution of normal porcine serum (Dako, High Wycombe, UK) in PBS. Primary antibodies used in this study were human type 1 procollagen (Gift from Dr M J Warburton, 16 St Georges Hospital Medical School, London and Chemicon International, Temicula, California, USA) and TGF-j (pan specific) (British Biotechnology Products Ltd, Oxon, UK). In initial experiments both antibodies to type 1 procollagen were compared in adjacent slides and gave identical results. The antibodies were diluted in 1 in 20 porcine serum in PBS. The sections were incubated with the optimal dilution of the primary antibodies (1 in 400 for procollagen-1 and 1 in 100 for TGF-1P in PBS)
for one hour in a humidifying chamber at room temperature. The sections were washed with PBS and incubated with biotinylated goat antirabbit (Dako) for 30 minutes, washed and then incubated with avidin-biotin peroxidase complex (Dako), washed for 15 minutes, and visualised with 3,3'-diaminobenzidine (DAB) substrate (Dako). The sections were counterstained with Mayer's haematoxylin solution (Sigma, St Louis, Missouri, USA) for one minute. After colour development, slides were scored for intensity in a coded fashion on a semiquantitative scale from negative (-), weak staining (+/-), definite staining (+), prominent staining ( + + ), and very definite staining (+ + +). Thus, sections were coded and examined without knowledge of clinical information. Perivascular and other cellular staining were assessed separately. In control sections specificity was ascertained when the primary antibody step was omitted or sections were treated with purified normal rabbit serum (Dako).
IN SITU HYBRIDISATION
The procedure for in situ hybridisation was modified from the methods described earlier. '7 Briefly, 3-4 jum sections were cut from tuberculin Heaf biopsy specimens embedded in paraffin wax and were mounted on Vector bond (Vector Laboratories, Burlingame, California, USA) coated slides and baked overnight at 56°C. Tissue sections were dewaxed and rehydrated through an alcohol series to PBS. Sections were treated with proteinase K (Boehringer Mannheim, UK) 50 ,um/ml for 7-5 minutes, washed in PBS followed by acetylation with 0 1% acetic anhydride in 0-1 M triethanolamine to reduce non-specific interaction between DNA probes and tissue. Slides were washed in PBS, dehydrated and air-dried, and used for hybridisation on the same day or stored at -200C.
For type 1 procollagen, two 27 base synthetic DNA oligonucleotide antisense sequences were made to order (British Biotechnology, UK) to be used as probes. The sequences were 5'-ACC AGT CTC ACC ACG ATC ACC ACT CTT-3' (-366 to -392) and 5'-TCC CTT AGC ACC AGT GTC TCC TTT GCT-3' (-2229 to -2255) and were deduced from the published DNA sequence of the human pro a (1) chain of human type 1 procollagen.'8 A cocktail of both oligonucleotides was 3'-end labelled with deoxyadenosine 5'-(a-35S) thiotriphos (Amersham International, Buckinghamshire, UK). The reaction consisted of 10pM of each oligonucleotides, 8 2G) . On day 5, the grades were from + to + + + for perivascular and from + to + + for cellular staining. The grades increased to + + to + + + for perivascular and to + to + + + for cellular staining on day 13 after the tuberculin Heaf Type 1 procollagen immunostaining with haematoxylin counterstain ( x 450) of sections from biopsy specimens of (A) normal skin, (B) skin five days after a tuberculin Heaf test, (C) skin group.bmj.com on June 15, 2017 -Published by http://jcp.bmj.com/ Downloaded from mixture of the same oligonucleotides before hybridisation. Conversely, prehybridisation with an excess of unlabelled irrelevant probe did not abolish the signal. The regional expression of type 1 procollagen mRNAs using in situ analysis and their immunohistochemical localisation in the upper dermal region revealed consistency between mRNA and protein expression ( figs 2C and 3A) . show any staining when incubated with normal purified rabbit serum ( fig 2D) . LOCALISATION (fig 3A) . Procollagen mRNA was occasionally observed in the perivascular areas in these specimens. Type 1 procollagen mRNA was not observed in sections from biopsy specimens on day 13 which were treated with ribonuclease A and T1 before hybridisation ( fig 3B) . In other experiments the hybridisation signal was abolished by prehybridization of sections with a 50-fold excess of "cold" (that is, unlabelled) antisense probe
Discussion
The demonstration of type 1 procollagen peptide and procollagen mRNA in biopsy specimens of the tuberculin tests in this study provides the first evidence in a human in vivo system of a link between the chronic inflammatory changes of a DTH response and the early stages of a fibrotic reaction. The presence of increased amounts of TGF-3, five days after the introduction of tuberculin, suggests that this growth factor may be involved in the transition from inflammation to fibrosis.
Previous studies on the Heaf test have focused on the immunological and inflammatory phase. The reaction is characterised by oedema, an influx of lymphocytes and monocytes, as well as increased vascular permeability. 19 
